Ophthalmic Devices: Technologies and Global Markets Research Report forecast
Summary - A new market study, titled “Ophthalmic Devices:
Technologies and Global Markets” has been featured on Wise Guy Reports.
In recent years there have
been significant advances in the development of ophthalmic devices and surgical
procedures that have helped to improve diagnosis and treatment of a broad range
of ophthalmic conditions, including cataracts, glaucoma, refractory and retinal
disorders.
The global market for ophthalmology devices2 reached nearly
$REDACTED billion in 2016. This market is estimated to reach more than
$REDACTED billion in 2022 from $REDACTED billion in 2017 at a compound
annualgrowth rate (CAGR) of REDACTED% for 2017 through 2022. The growth is
being driven by the launch of newbiocompatible materials, improvements in
clinical optics and the launch of high-end surgical devices.Advancements in
cataract and refractory surgery devices have also resulted in the improved
safety andefficacy of routine procedures, helping to improve surgical outcomes,
reduce perioperative morbidityand increase the number of patients willing to
undergo surgery.
In 2016, The United States represents the largest segment of
ophthalmology device sales, accounting for REDACTED% of global revenues,
followed by Europe with REDACTED% and Asia-Pacific with REDACTED%. The
globalophthalmology device market is being driven by patient demographics such
as the rising incidence ofdiabetes and obesity and the increasing geriatric
population, which is increasing the number of patientswith conditions such as
age-related macular degeneration, cataracts, diabetic retinopathy and glaucoma,
and helping to expand the addressable patient population in need of ophthalmic
devices. Inaddition, market growth is being aided by growing awareness and
early detection
and monitoring ofocular disease, the rise in adoption of
minimally invasive surgeries in Asia-Pacific, greater healthcareinsurance
coverage in Europe and positive reimbursement of ocular devices and surgical
procedures inthe United States.
In 2016, the ophthalmology device market is composed of
several segments: vision care contact lenses (REDACTED%), intraocular lenses
(IOLs) and other cataract surgery products (REDACTED%), diagnostic and
imagingdevices (REDACTED%) and other surgery devices (REDACTED%). The market is
dominated by a few players: Alcon,Bausch & Lomb, Carl Zeiss Meditec,
CooperVision, Johnson & Johnson, Nidek, Topcon Corp and ValeantPharmaceuticals
(Bausch & Lomb). Innovative new companies such as EyeKon Medical, Glaukos
Corp.,Optos and others, are gradually making headway in the market. Within the
market, Alcon is thedominant player, with its sales accounting for REDACTED% of
the entire market.
The contact lens market accounts for nearly half of global
sales, generating over $8.6 billion in 2016. This market is estimated to reach
around $REDACTED billion in 2022 from $REDACTED billion in 2017 at a CAGR of
REDACTED% for2017 through 2022. The market is dominated by Johnson &
Johnson, with a REDACTED% market share,followed by Alcon (a Novartis company)
with REDACTED%, CooperVision with REDACTED%, and Bausch & Lomb
(ValeantPharmaceuticalGroup)withREDACTED%.Report Scope:
This report on ophthalmic devices provides a brief
description of the current status of the industry and recent developments. The
report analyzes the market trends and identifies key medical and geographical
challenges and rising opportunities in the developed and developing world.
Finally, it will provide insights regarding new developments into ophthalmic
and surgical devices that help to improve diagnosis and enhance the treatment
of cataracts, glaucoma, refractory and retinal disorders.
Report Includes:
- 21 data tables
- A comprehensive analysis of the market for ophthalmic
devices by reviewing recent advances in diagnostic, surgical, and implantation
devices that can be used to treat prevalent eye conditions
- Analyses of global market trends, with data from 2016, estimates
for 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Analysis of the recent advances in ophthalmic medical
devices and their potential impact on the medical device industry
- Evaluation of the market's dynamics, specifically growth
drivers, restraints, and opportunities
- Company profiles of major key players in the market,
including Abbott Medical Optics, Alcon, Bausch & Lomb, Carl Zeiss Meditec,
Johnson & Johnson, Quantel Medical, Topcon and Ziemer Ophthalmic Systems AGABBOTT
MEDICAL OPTICS
ALCON
ALLERGAN
AVEDRO INC.
BAUSCH & LOMB
BIO-TISSUE INC.
CARL ZEISS MEDITEC AG
COOPERVISION
DUTCH OPHTHALMIC RESEARCH CENTER INTERNATIONAL BV
ELLEX MEDICAL LASERS
EYENUK INC.
GLAUKOS
HEIDELBERG ENGINEERING GMBH
HOYA CORP.
IOPTIMA LTD.
IRIDEX CORP.
JOHNSON & JOHNSON
LENSTEC INC.
LUMENIS
NIDEK Inc.
OASIS MEDICAL INC.
Optovue Inc.
QUANTEL MEDICAL
SAV-IOL SA
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD.
SIGHT SCIENCES INC.
SOFTCARE SOLUTION INC.
STAAR SURGICAL
TEARSCIENCE INC.
TOPCON
VASOPTIC MEDICAL INC.
ZIEMER OPHTHALMIC SYSTEMS AG
FOR MORE DETAILS: https://www.wiseguyreports.com/reports/3168767-ophthalmic-devices-technologies-and-global-markets
About
Us :
Wise Guy Reports is part of the Wise Guy Research
Consultants Pvt. Ltd. and offers premium progressive statistical surveying,
market research reports, analysis & forecast data for industries and
governments around the globe.
Contact
Us:
NORAH
TRENT
Ph: +162-825-80070
(US)
Ph: +44 203
500 2763 (UK)
Comments
Post a Comment